Structure of a Cyclic Peptide as an Inhibitor of <i>Mycobacterium tuberculosis</i> Transcription: NMR and Molecular Dynamics Simulations
Background and Objectives: A novel antitubercular cyclic peptide, Cyclo(1,6)-Ac-CLYHFC-NH<sub>2</sub>, was designed to bind at the rifampicin (RIF) binding site on the RNA polymerase (RNAP) of <i>Mycobacterium tuberculosis</i> (MTB). This peptide inhibits RNA elongation in th...
Saved in:
Main Authors: | Filia Stephanie (Author), Usman Sumo Friend Tambunan (Author), Krzysztof Kuczera (Author), Teruna J. Siahaan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
by: Filia Stephanie, et al.
Published: (2021) -
Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
by: Kavisha R. Ulapane, et al.
Published: (2019) -
The Mechanism of Action of SAAP-148 Antimicrobial Peptide as Studied with NMR and Molecular Dynamics Simulations
by: Morgane Adélaïde, et al.
Published: (2023) -
Mechanisms of a <i>Mycobacterium tuberculosis</i> Active Peptide
by: Komal Umashankar Rao, et al.
Published: (2023) -
Modification of -Adenosyl--Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
by: Usman Sumo Friend Tambunan, et al.
Published: (2017)